Biotech Stocks: Smalls Flexing Muscle.

Kiplinger Business Forecasts, April, 2002

Byline:Richard Sammon

While they are largely unknown outside the industry, a number of small and medium-size biotechnology firms are catching the eye of more investors and financial analysts who are intrigued by the potential demand for new and often lifesaving pharmaceuticals.

Along with other technology sectors, biotech has soared and tanked at various times in the last few years and has recorded an uneven performance in the last 12 months. But the sector is filled with notable standouts.

Stocks of standard-bearers like Genentech and Amgen slid quickly with the rest of the market after Sept. 11, but they quickly regained lost ground. Their rebound reflects the general resiliency and appeal of biotech companies, which continue to attract...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.